|
Index of reports
> Cases resulting in death (12)
> Cases with Jaundice (7)
Below is the selection of adverse event reports related to Lamisil (Terbinafine) that includes cases resulting in death where reactions include jaundice.
Adverse event in 49 year old male receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-07-26
Patient: 49 year old male
Adverse reactions / side effects: Abdominal Pain, Asthma, Nasopharyngitis, Pruritus, Tongue Discolouration, Leukoplakia, Pyrexia, Appetite Disorder, Enterococcal Sepsis, DRY Mouth, Hiccups, Biopsy Liver, Blood Creatinine Increased, Cough, Chest Discomfort, Anaemia, Hypotension, Chromaturia, Nasal Congestion, Rhinitis Allergic, Bronchitis Chronic, Anorexia, Ocular Hyperaemia, Ocular Icterus, Sputum Discoloured, Jaundice, Hyperbilirubinaemia, Food Intolerance, Eye Irritation, Wheezing, Chills, Drug Interaction, Liver Disorder, Liver Transplant, Fatigue, Haematocrit Decreased, Hepatorenal Syndrome, Pharyngolaryngeal Pain, Chronic Hepatic Failure, Pharyngitis, Renal Failure Acute, Dyspnoea, Hepatic Pain, Vomiting, Nausea, Tongue Coated, Hepatic Enzyme Increased, Haematochezia, Haemoglobin Decreased, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Biaxin XL
Start date: 2005-04-12
Lamisil
Dosage: 250 mg, qd
Administration route: Oral
Indication: Tinea Pedis
Start date: 2005-01-20
End date: 2005-05-01
Other drugs received by patient: Antihypertensives; Lotrel; Nizoral; Decadron; Astelin; Nasonex; Flonase
Adverse event in 49 year old male receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-07-26
Patient: 49 year old male
Adverse reactions / side effects: Abdominal Pain, Asthma, Nasopharyngitis, Pruritus, Tongue Discolouration, Leukoplakia, Pyrexia, Appetite Disorder, Enterococcal Sepsis, DRY Mouth, Hiccups, Biopsy Liver, Blood Creatinine Increased, Cough, Chest Discomfort, Anaemia, Hypotension, Chromaturia, Nasal Congestion, Rhinitis Allergic, Bronchitis Chronic, Anorexia, Ocular Hyperaemia, Ocular Icterus, Sputum Discoloured, Jaundice, Hyperbilirubinaemia, Food Intolerance, Eye Irritation, Wheezing, Chills, Drug Interaction, Liver Disorder, Liver Transplant, Fatigue, Haematocrit Decreased, Hepatorenal Syndrome, Pharyngolaryngeal Pain, Chronic Hepatic Failure, Pharyngitis, Renal Failure Acute, Dyspnoea, Hepatic Pain, Vomiting, Nausea, Tongue Coated, Hepatic Enzyme Increased, Haematochezia, Haemoglobin Decreased, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Biaxin XL
Start date: 2005-04-12
Lamisil
Dosage: 250 mg, qd
Administration route: Oral
Indication: Tinea Pedis
Start date: 2005-01-20
End date: 2005-05-01
Other drugs received by patient: Antihypertensives; Lotrel; Nizoral; Decadron; Astelin; Nasonex; Flonase
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-04-02
Patient: 81 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Malaise, Hepatic Encephalopathy, C-Reactive Protein Increased, Melaena, Blood Creatinine Increased, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Metabolic Acidosis, Haemodialysis, Heart Rate Decreased, Micturition Disorder, Bacteraemia, Aspartate Aminotransferase Increased, Septic Shock, Jaundice, Drug Interaction, Cholestasis, Liver Disorder, Haematocrit Decreased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Bacterial Infection, Tachypnoea, Blood Urea Increased, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemoglobin Decreased, Renal Failure, Respiratory Acidosis, Blood Pressure Decreased, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-03-08
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-03-05
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-02-16
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-02-09
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
|
